+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Cardiovascular Information System Market Size, Share & Industry Trends Analysis Report By Type (CVIS, and CPACS), By Mode Of Operation (Web-based, Cloud-based, and On-site), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • October 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935777
The Europe Cardiovascular Information System Market would witness market growth of 10.0% CAGR during the forecast period (2023-2030).

The introduction of digital technology, along with the widespread use of EHRs, has contributed to the market's expansion. The transition from paper-based records to digital solutions has significantly shifted how healthcare information is managed. In cardiology departments, the need for integrated digital systems has become paramount. CVIS is designed to be an integral component in this digital transformation, allowing healthcare providers to access and share patient data, diagnostic images, and test results electronically.

The need for CVIS grows as early detection of cardiovascular issues is necessary to begin treatment and medication. These systems improve the software's productivity, effectiveness, and patient records. Their demand is higher since they are more effective than conventional processing and storing patient cardiac data.

According to the same source, Bulgaria had the highest rate of standard mortality rates for cerebrovascular diseases among EU Member States in 2019 and was 7.7 times higher than Luxembourg, which had the lowest rate. In 2020, Germany performed 38,900 heart bypasses, more than twice as many as any other EU Member State (16,400 were performed in France). As a result, regional governments have increased their efforts to bolster access to healthcare. This improves the overall patient experience and empowers individuals to be more active participants in their healthcare. These factors collectively contribute to the growing adoption of CVIS in Europe, reflecting the region's commitment to digital healthcare, data-driven decision-making, and the provision of high-quality cardiovascular care to its population.

The Germany market dominated the Europe Cardiovascular Information System Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $151.3 Million by 2030. The UK market is exhibiting a CAGR of 9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 10.8% during (2023 - 2030).

Based on Type, the market is segmented into CVIS, and CPACS. Based on Mode Of Operation, the market is segmented into Web-based, Cloud-based, and On-site. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation

Scope of the Study

Market Segments Covered in the Report:

By Type
  • CVIS
  • CPACS
By Mode Of Operation
  • Web-based
  • Cloud-based
  • On-site
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Cisco Systems, Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Cerner Corporation (Oracle Corporation)
  • Lumedx Corporation (Intelerad Medical Systems Incorporated)
  • Agfa-Gevaert Group
  • Honeywell International, Inc.
  • McKesson Corporation

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cardiovascular Information System Market, by Type
1.4.2 Europe Cardiovascular Information System Market, by Mode Of Operation
1.4.3 Europe Cardiovascular Information System Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2022
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Mergers & Acquisition: 2020, Aug - 2023, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Cardiovascular Information System Market, by Type
5.1 Europe CVIS Market, by Country
5.2 Europe CPACS Market, by Country
Chapter 6. Europe Cardiovascular Information System Market, by Mode Of Operation
6.1 Europe Web-based Market, by Country
6.2 Europe Cloud-based Market, by Country
6.3 Europe On-site Market, by Country
Chapter 7. Europe Cardiovascular Information System Market, by Country
7.1 Germany Cardiovascular Information System Market
7.1.1 Germany Cardiovascular Information System Market, by Type
7.1.2 Germany Cardiovascular Information System Market, by Mode Of Operation
7.2 UK Cardiovascular Information System Market
7.2.1 UK Cardiovascular Information System Market, by Type
7.2.2 UK Cardiovascular Information System Market, by Mode Of Operation
7.3 France Cardiovascular Information System Market
7.3.1 France Cardiovascular Information System Market, by Type
7.3.2 France Cardiovascular Information System Market, by Mode Of Operation
7.4 Russia Cardiovascular Information System Market
7.4.1 Russia Cardiovascular Information System Market, by Type
7.4.2 Russia Cardiovascular Information System Market, by Mode Of Operation
7.5 Spain Cardiovascular Information System Market
7.5.1 Spain Cardiovascular Information System Market, by Type
7.5.2 Spain Cardiovascular Information System Market, by Mode Of Operation
7.6 Italy Cardiovascular Information System Market
7.6.1 Italy Cardiovascular Information System Market, by Type
7.6.2 Italy Cardiovascular Information System Market, by Mode Of Operation
7.7 Rest of Europe Cardiovascular Information System Market
7.7.1 Rest of Europe Cardiovascular Information System Market, by Type
7.7.2 Rest of Europe Cardiovascular Information System Market, by Mode Of Operation
Chapter 8. Company Profiles
8.1 Koninklijke Philips N.V.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Cisco Systems, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Fujifilm Holdings Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Siemens Healthineers AG (Siemens AG)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Oracle Corporation (Cerner Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Intelerad Medical Systems Incorporated (Lumedx Corporation)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.3 SWOT Analysis
8.8 Agfa-Gevaert Group
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Honeywell International, Inc.
8.9.1 Company Overview
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.6 SWOT Analysis
8.10. McKesson Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
8.10.6 SWOT Analysis

Companies Mentioned

  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Cisco Systems, Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Cerner Corporation (Oracle Corporation)
  • Lumedx Corporation (Intelerad Medical Systems Incorporated)
  • Agfa-Gevaert Group
  • Honeywell International, Inc.
  • McKesson Corporation

Methodology

Loading
LOADING...